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ABSTRACT It has been emphasized that prurigo simplex subacuta may be asso-
ciated with various disorders and may be clinically confused with dermatitis her-
petiformis. Aim of the study was to evaluate the value of our set of tests for finding 
possible associations and for the aforementioned differential diagnosis. Rates of 
implementations and abnormal results in our set of tests, including skin prick test, 
skin biopsy, complete blood count, blood chemistry panel, and psychiatric evalu-
ation were analyzed retrospectively between the years of 2010 and 2015 in 130 
patients clinically diagnosed with prurigo simplex subacuta. The set of tests was 
implemented completely in 43.8% patients and with only a single missing test in 
31.5% of the patients. The least implemented procedure was psychiatric evaluation 
(66.9%). The most commonly found issues were psychiatric abnormalities (55.2% 
of 87 psychiatrically evaluated patients) and atopy (53.8% of 104 skin prick tested 
patients). The most common finding suggestive of internal diseases was hypergly-
cemia (25.4% of 130 patients). It was a striking result that hematological malignan-
cies were suspected upon complete blood count and peripheral blood smear and 
confirmed by further investigations in 4 of 102 patients. Dermatitis herpetiformis 
was diagnosed in 2 of 120 skin biopsied patients. Because of the substantial rate of 
implementation, the high frequencies of psychiatric abnormalities and atopy, and 
detection of hematological malignancies and dermatitis herpetiformis even in just 
a few patients, we recommend our set of tests for patients clinically diagnosed as 
prurigo simplex subacuta.
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INTRodUCTIoN 
Prurigo simplex subacuta (PSS), also known as 
“itchy red bump disease” or “papular dermatitis”, is 
clinically characterized by discrete, pale red papules, 
which itch intensely, thereafter rapidly evolving into 
excoriations, and are symmetrically distributed espe-
cially on the extensor surfaces of the limbs (1,2). Its 
associations with atopy and with various internal dis-
eases are well known (3). Moreover, these associations 
have been emphasized with the use of terms such as 
prurigo Besnier, prurigo diabetica, prurigo uremica, 
prurigo hepatica, and prurigo lymphatica. PSS is clas-
sified among psychosomatic skin diseases, in which 
emotional factors play an important role in the eti-
ology (4,5). Although it can be readily distinguished 
from dermatitis herpetiformis (DH) histopathologi-
cally, the clinical differential diagnosis between the 
two may be difficult (6,7).
In the light of these data, we had previously deter-
mined tests necessary in patients with lesions clini-
cally suggestive of PSS. These tests were the skin prick 
test with common aeroallergens, skin biopsy, fasting 
blood sugar measurement, kidney, liver, and thyroid 
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function tests, complete blood count, peripheral 
blood smear, and clinical evaluation by a psychiatrist. 
In this study, we reviewed the records of 130 such pa-
tients in order to determine the rate of implementa-
tion of these tests and more importantly the frequen-
cies of their abnormal results and consequently the 
level of necessity of each test. 
Patients and Methods
We searched for patients clinically diagnosed 
with PSS in the computerized medical records of our 
Department between 2010 and 2015. One hundred 
and thirty such patients were found. Their records 
were reviewed, especially for data concerning der-
matological and systemic clinical findings along with 
the following tests: (1) skin prick test with common 
aeroallergens to detect atopy; (2) histopathological 
examination and direct immunofluorescence test of 
a skin biopsy specimen to make a differential diag-
nosis with DH; (3) fasting blood sugar measurement 
to detect hyperglycemia; (4) blood urea nitrogen and 
serum creatinine measurements to detect abnormal 
renal function; (5) serum alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) measure-
ments to detect abnormal liver function; (6) serum 
thyroid stimulating hormone (TSH) and free thyrox-
ine-4 measurements to detect abnormal thyroid func-
tion; (7) complete blood count and peripheral blood 
smear hematological malignancies; and (8) clinical 
evaluation by a psychiatrist.
The rate of implementation of each of these eight 
tests was calculated. Additionally, the frequencies 
of abnormal results in these tests were determined. 
Comparisons between the subgroups of the patients 
in frequency of abnormal results were statistically 
analyzed using by the chi-square test. The ethics ap-
proval for this study was obtained from the University 
of Çukurova Research Ethics Board. 
RESULTS
Of 130 patients with PSS, 85 (65.4%) were women 
and 45 (34.6%) men. Their minimum, maximum, av-
erage, and median ages were 17, 88, 51.8 (Standard 
Deviation (SD) ± 5.7), and 51.5 years, respectively. The 
duration of their diseases were between 1 month and 
30 years, with a median of 15 months. All patients 
had been treated with antiscabietics, but their itchy 
papules persisted. Moreover, there was no sign sug-
gestive of insect bites in their recent medical histo-
ries and physical examinations or any specific drug 
history that could have provoked PSS.
A skin prick test was performed in 104 patients 
(80%); skin biopsy in 120 (92.3%); fasting blood sugar 
measurement in 130 (100%); renal function tests in 
130 (100%); liver function tests in 130 (100%); thy-
roid function tests in 120 (92.3%); screening tests 
for hematological malignancies in 102 (78.5%); and 
psychiatric evaluation in 87 (66.9%). Among these 8 
tests, all 8 were performed in 57 (43.8%) patients, 7 in 
41 (31.5%), 6 in 21 (16.2%), 5 in 10 (7.7%), and 4 in 1 
(0.8%) patient.
Atopy, i.e. skin prick test positivity, was found in 
53.8% (56/104) of patients. Histopathological ex-
amination showed only postinflammatory hyperpig-
mentation in 1 patient and only crust formation in 2 
patients. Histopathological findings were consistent 
with PSS in 115 patients. In the remaining 2 patients, 
histopathological and immunopathological findings 
were consistent with DH. The common clinical find-
ing of these two patients was that intact vesicles were 
found among excoriated papules, even if few in num-
ber.  Hyperglycemia was found in 25.4% (33/130) of 
patients. Abnormal renal, liver, and thyroid function 
tests were observed in 5.4% (7/130), 2.3% (3/130), 
and 8.3% (10/120) of patients, respectively. Hemato-
logical malignancies were suspected upon complete 
blood count and peripheral blood smear and con-
firmed by further tests in 3.9% (4/102) of patients. 
They were myelodysplastic syndrome in 2, hairy cell 
leukemia in 1, and chronic lymphocytic leukemia in 1 
patient. Of 87 patients in whom a clinical evaluation 
by a psychiatrist was performed, 48 (55.2%) had psy-
chiatric abnormalities. Anxiety disorder was found in 
22, depressive disorder in 17, somatoform disorder in 
3, and other psychiatric disorders in 6 patients.
Briefly, the most common issues found in our tests 
for PSS were atopy and psychiatric abnormalities. The 
frequency of atopy was not significantly different be-
tween male and female patients (24/37 versus 32/67), 
between patients aged up to 51.5 years, which was 
the median age of our patients, and older patients 
(30/56 versus 26/48), and between patients having 
the disease for up to 15 months and patients with 
a more prolonged disease (30/56 versus 26/48). This 
was also valid for psychiatric abnormalities (male ver-
sus female patients: 12/27 versus 36/60; younger ver-
sus older patients: 22/41 versus 26/46; patients with a 
shorter disease duration versus a longer disease du-
ration: 23/45 versus 25/42).
dISCUSSIoN
With decreasing order of frequency, the issues 
which were found in this study by our seven tests 
were psychiatric abnormalities (55.2%), atopy (53.8%), 
hyperglycemia (25.4%), abnormal thyroid function 
tests (8.3%), abnormal renal function tests (5.4%), 
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findings suggestive of hematological malignancies 
(3.9%), and abnormal liver function tests (2.3%). As 
the eighth test, histopathological and immunopath-
ological examination resulted in findings consistent 
with DH in 2 (1.7%) of the 120 patients, in whom a 
skin biopsy was taken.
Although the main purpose of this study was to 
determine the levels of necessity of tests which were 
done in our patients with PSS depending on the fre-
quencies of their abnormal results, such a determina-
tion also requires some evaluation other than exam-
ining these frequencies. First of all, they should be 
compared with the frequencies of abnormal results 
of the same tests in the general population. 
In 2013, the Health Ministry of Turkey published 
a report about the prevalence of chronic diseases in 
Turkey (8). According to this report, the standardized 
rate of mental health problems was 11.3%. This rate 
was different for men and women, 7.1% and 15.5%, 
respectively. These rates were even somewhat lower 
in the Mediterranean region where our city is located, 
6.5% and 15.2%, respectively. Thus, it was very obvi-
ous that, in our patients, PSS was associated with a 
markedly increased prevalence of psychiatric abnor-
malities. Therefore, clinical evaluation by a psychiatrist 
was a very necessary procedure for these patients. 
We could not find any data from our city, Adana, 
on the prevalence of atopy in the general population. 
In a population-based epidemiological study from 
Ankara, the capital city of Turkey, skin prick tests were 
found to be positive for at least one aeroallergen in 
25% of the participants (9). In a similar study from An-
talya, a city located in the Mediterranean region, this 
figure was 31.1% (10). A similar study was also done 
in city nearer to ours, namely Gaziantep. In this study, 
the sample was chosen from the general population 
of the city center. However, skin prick-tested subjects 
were not randomly chosen from the sample, but 
where rather subjects who had allergy or respiratory 
complaints in the past year, and constituted the risk 
group. The frequency of positive skin prick tests in 
these subjects was almost 44% for adults (11). The fre-
quency in our patients with PSS was higher (53.6%) 
even than that of this risk group. Moreover, our fre-
quency was not far from the rate of 61.8%, which was 
obtained in patients with atopic dermatitis in a study 
done in Dörtyol, a town very close to our city (12). 
Therefore, it is most likely that PSS in our patients was 
associated with an increased prevalence of atopy. The 
skin prick test was thus a necessary test in these pa-
tients.
In a report by the Health Ministry of Turkey, the 
rate of subjects with impaired fasting plasma glucose 
or with diabetes mellitus was 26.9% in the general 
population (8). The rate of hyperglycemia in our pa-
tients with PSS was not higher; on the contrary, it was 
slightly lower. In a study performed on 512 Turkish 
adults, the prevalence of hypothyroidism was found 
to be 4.4% and that of hyperthyroidism was 4.7%, 
according to TSH levels (13). Our rate of abnormal 
thyroid function tests was not higher than the sum 
of these rates but was, again, slightly lower. Thus, 
at first glance, one might say that measurements of 
fasting blood sugar, serum TSH, and free thyroxine-4 
are not necessary tests in PSS. However, the associa-
tion of this disease with diabetes mellitus and thyroid 
diseases have been emphasized some texts dealing 
with its etiology (3,14-16). Moreover, these measure-
ments are inexpensive, at least in our country. On the 
other hand, as mentioned above, this disease is as-
sociated with psychiatric abnormalities in over half of 
the patients (4,5). However, as seen in our data, the 
implementation rate of clinical evaluation by a psy-
chiatrist is low, at least in our country, partly because 
of patient resistance. Using simple tests showing a 
patient that there is no internal cause for their itching 
may reassure them, thus breaking their resistance to 
a psychiatric evaluation.
In a population-based survey of chronic renal 
disease in Turkey, which was performed on over 
10000 subjects, the prevalence of chronic renal dis-
ease (CRD) was found to be 15.7% according to mi-
cro- or macro-albuminuria and glomerular filtration 
rate (17). Our rate of abnormal renal function tests 
was markedly lower than this rate. However, it is well 
known that serum creatinine levels do not increase 
until a moderate to severe reduction in glomerular 
filtration rate occurs (18). Thus, our rate corresponds 
to that of at least CRD Stage 3. The sum of rates for 
CRD Stage 3, 4, and 5 (5.2%) in that study was almost 
equal to our rate (5.8%). In a study from the Northern 
Turkey, the prevalence of elevated serum ALT and/or 
AST was found to be 13.3% (19). Our rate of abnormal 
liver function tests was markedly lower than this rate. 
This might be explained by regional differences, since 
our city is located in Southern Turkey. Based on these 
findings one might also say that testing blood urea 
nitrogen, serum creatinine, ALT, and AST are not nec-
essary tests in PSS. However, the association of this 
disease with chronic kidney and liver failure has been 
emphasized in almost all texts dealing with its etiol-
ogy (3,14-16). Therefore, as with the measurements 
discussed above, renal and liver function tests should 
also be performed in all patients with PSS.
We could not find any suitable data for com-
parison of the rate of hematological malignancies 
found in our study. However, we believe that such a 
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comparison is not obligatory to evaluate the place of 
complete blood count and peripheral blood smear as 
tests in PSS, since they are of great value in detect-
ing hematological malignancy even in only a single 
malignancy can be detected using these readily avail-
able screening tests.
We could not find any general population-based 
data from Turkey to compare it to the rate of DH ob-
served in our study. This rate (1.7%), however, was 
much higher than the prevalence of DH reported 
from various other countries (20-22). More impor-
tantly, DH does not usually improve significantly with 
nonspecific antipruritic remedies, topical corticoste-
roids, which are the main agents in the symptomatic 
treatment of PSS, and requires a specific drug, namely 
dapsone. It was thus of great value to establish the 
correct diagnosis via skin biopsy even in only a single 
case among patients having lesions suggestive of 
PSS. Skin biopsy should therefore be performed at 
least in patients with intact vesicles among excori-
ated papules, and in those who do not improve with 
treatment based on the results of other tests and with 
nonspecific antipruritic remedies and topical cortico-
steroids.
CoNCLUSIoN
We recommend these eight tests in cases PSS for 
the following reasons: atopy and psychiatric abnor-
malities may be found in the majority of the patients; 
they have great value in detecting hematological ma-
lignancies and establishing a diagnosis of DH even if 
the number of detected cases is low; the exclusion of 
internal diseases may reassure the patients; and finally 
the rate of implementation of these eight tests is high.
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